Blog
Follow us for the latest trends, insights and innovations in the pharmaceutical industry.
Orforglipron: A New Oral GLP-1 Option Redefining Weight Management
Orforglipron is Eli Lilly’s oral GLP-1 receptor agonist for weight management, currently under FDA review. This article examines its clinical background, weight-maintenance data, and implications ...
Read More →
Batch-to-Batch Consistency: Why It Matters for Intermediates
Learn why batch-to-batch consistency is critical for pharmaceutical intermediates, impacting impurity control, scale-up success, and regulatory compliance.
Read More →
Oncology Intermediates: Technical Challenges & Quality Expectations
This article examines the core technical challenges faced during oncology intermediate manufacturing, including reaction selectivity control, impurity structural fixation, and scale-up consistency risks.
Read More →
Scale-Up Challenges for Intermediates: Ensuring a Smooth Transition from Lab to Commercial Production
This article provides an in-depth analysis of the most common scale-up challenges encountered during the production of pharmaceutical intermediates.
Read More →